Plaintiffs who sue may beef up or totally falsify their alleged injuries in an effort to recover more money. Here's how the defense can spoil their schemes.
Medscape Business of Medicine
Daily Archives: 2011/07/08
AHAF awards 22 new grants to scientists worldwide for innovative vision research
The American Health Assistance Foundation (AHAF), a nonprofit organization with a history of funding cutting-edge research on age-related diseases, announced today that it has awarded 22 new grants totaling nearly $2.2 million to scientists worldwide who are studying glaucoma and macular degeneration. The two conditions are the leading causes of irreversible vision loss and blindness in the U.S.
Foundation Fighting Blindness Launches Human Study To Treat Blinding Disease With Valproic Acid
The Foundation Fighting Blindness has launched a Phase II clinical trial of valproic acid, now underway, to evaluate the drug's effectiveness in slowing vision loss for people with autosomal dominant forms of retinitis pigmentosa (adRP), an inherited retinal degeneration that progressively leads to blindness. Autosomal dominant forms affect multiple generations within families.
Deep Sclerectomy Controls IOP Over The Long Term
Ten years of follow-up showed that deep sclerectomy provides long-term control of IOP with minimal use of adjunctive medical therapy, according to a surgeon speaking here.
Subscribe
